fbpx
Connect with us

Press Releases

VEON’s Beeline and Leading Medical Institute Join Forces to Redefine Future of Medical Diagnostics Through AI

Published

 on

VEON Ltd. (NASDAQ: VEON, Euronext Amsterdam: VEON), a leading global provider of connectivity and internet services, announced on October 12, that its mobile operator in Russia, Beeline, has signed an agreement with Sechenov University to create an Artificial Intelligence (AI) Laboratory for research and development into new technology solutions for healthcare, aiming to simplify and accelerate high-precision diagnostic. 

The new AI Laboratory will see data scientists and doctors collaborate on research and development of predictive medicine solutions in traumatology and oncology. Over 120 professionals from Beeline and Sechenov University, including data scientists, solution architects, neural network programmers and medical experts, will be involved in the new AI Lab to provide a critical mass of expertise. The AI Labs will undertake specific research programmes, scientific exchange and staff secondments, with IT infrastructure provided by Beeline’s datacentres. 

“Technology based on artificial intelligence is transforming modern medicine” states Kaan Terzioglu, CEO of VEON Group.  “We have invested in AI at the core of our digital operator businesses and are proud of our contribution to the development of state-of-the-art technology. This will be a game-changer in the way we support medical institutions, save lives and keep people healthy throughout their lifetime.” 

“This joint AI Lab will enable smart software solutions to be trained by findings from some of the best doctors in the industry and so help to significantly simplify and expedite high-precision diagnostics processes. said Evgeny Chereshnev, Executive Vice President of Beeline for Digital and New Business Development. “This greatly increases the chances of successful treatment of patients, and sometimes, literally saves lives. Our partnership with Sechenov University is a new direction for Beeline which is already yielding results. Sechenov’s experts are some of the best in the world, and we are delighted to be working with them to develop and apply high-tech solutions.” 

“Our partnership with Beeline began earlier this year. In particular, we focused on the study of joint pathology in the framework of Laboratory of Smart Nanotechnology for Clinical Applications supported by Megagrant from Ministry of Science and Higher Education of the Russian Federation. Based on the analysis of more than 4,000 medical records, we managed to create a model that determines the type of pathology and its localization with over 80% accuracy. This technological solution can help doctors significantly accelerate the process of diagnosing joint pathologies and its accuracy, and also makes it possible to predict the possible disease, track the effectiveness of treatment and dynamically make adjustments to it. For a patient, this can open the way for timely help and medical treatment instead of surgery,” explains Petr Glybochko, Academician of the Russian Academy of Sciences, prof., MD, Rector of the Sechenov University. “The next step would be to work with the Russian healthcare system to test AI diagnostics in a clinical environment. In the future, we plan to extend our work to the field of cardiology, immunology, pulmonology and post-covid therapy.” 

“The development of AI solutions in medicine and their introduction into practical healthcare will enable the solving of complex diagnostic problems at a new level. New software solutions, based on the use of neural networks and artificial intelligence will be integrated in electronical medical records for the Russian Healthcare System. The project will create a collaboration of IT engineers and medical experts that builds the preconditions for a real technological breakthrough.  This can enable the creation of “digital twins” and their introduction into clinical practice. This is one of the main directions of development of Sechenov University within the framework of the Priority 2030 project, which will be implemented thanks to the cooperation of specialists from Sechenov University and VEON’s Beeline,” said Petr Glybochko, Academician of the Russian Academy of Sciences, prof., MD, Rector of the Sechenov University.

About VEON  


VEON is a NASDAQ and Euronext Amsterdam-listed global provider of connectivity and digital services. Our companies are transforming lifestyles through technology-driven services that empower opportunity in some of the world’s fastest-growing emerging markets. For more information, visit: https://www.veon.com  

About Sechenov University 

Sechenov University is the oldest medical school in Russia. Currently, it has more than 21,000 students (20% international). Teaching and research staff (2,263 people) work at 115 departments. Sechenov University has 23 research institutes, 6 of them form the Biomedical Science and Technology Park. Sechenov University offers courses in clinical medicine (general medicine, paediatrics, dentistry), preventive medicine, pharmacy, nursing, social work, public health, management, medical biophysics, medical biochemistry, biotechnology, bioengineering and bioinformatics, clinical psychology, defectology, linguistics, mathematical modelling, IT, and materials science. 

Disclaimer  

This release contains “forward-looking statements”, as the phrase is defined in Section 27A of the U.S. Securities Act of 1933, as amended, and Section 21E of the U.S. Securities Exchange Act of 1934, as amended. Forward-looking statements are not historical facts, and include statements relating to, among other things, expectations regarding management plans and future performance. Forward-looking statements are inherently subject to risks and uncertainties, many of which VEON cannot predict with accuracy and some of which VEON might not even anticipate. The forward-looking statements contained in this release speak only as of the date of this release. VEON does not undertake to publicly update, except as required by U.S. federal securities laws, any forward-looking statement to reflect events or circumstances after such dates or to reflect the occurrence of unanticipated events. 

Contact Information  

Marina Levina 

VEON Group 

Group Communications Director 

Marina.levina@veon.com 

Julian Tanner 

TUVA Partners 
julian.tanner@tuvapartners.com 

We’re a diverse group of industry professionals from all corners of the world. Our desire is to provide a high-quality telecoms publication that caters to an international market, offering the latest and most relevant telecoms information to businesses, entrepreneurs and enthusiasts.

Press Releases

Monty Mobile: The First Company in the Middle East & Africa to Provide 5G End-to-End Solutions for Telcos

Published

 on

5G End-to-End Solutions for Telcos

Monty Mobile provides an in-house, cost-effective, well-optimized 4G+ and 5G end-to-end wireless solution serving both small and large-scale mobile and fixed operators targeting both urban and rural areas.

Moreover, operators are offered flexible payment plans for up to 5 years, first payment after 3 years, helping them stay ahead of their competitors.

This on- cloud solution guarantees improved scalability, mobility and security in addition to great savings on both CapEx and OpEx.

With this solution, Monty Mobile is introducing an alternative to Tier1 Telecom Suppliers such as Ericsson, Huawei, Nokia, and ZTE.

“The best is yet to come; stay connected!”, says Mountasser Hachem, Founder & Chairman of Monty Mobile.

More details regarding this full end-to-end solution will be disclosed in the Inside Telecom magazine next month in an exclusive interview.

Continue Reading

Press Releases

Africa’s Leading Independent Telecommunications Services Provider, Phase3 Telecom moves onto Digital Connectivity Enterprise in Nigeria and West African Sub-region

Published

 on

The upgrades will cover security features, performance enhancements. agile update capacity and quality delivery mechanisms.

ABUJA, Nigeria, March 10, 2022: Africa’s leading independent aerial fiber optic network infrastructure and telecommunications services provider, Phase3 Telecom, is enabling advanced digital connectivity, improved performance and enhanced network security for enterprise. This drive is targeted at cost efficient and unified network endpoint management for businesses in Nigeria and the West African sub-region.

This development is also designed to amplify Phase3 enterprise value active network deployments for MSMEs, large scale corporates and institutions.

According to the company’s executive chairman – Stanley Jegede, “this expansive service optimization is targeted at improved coverage on Phase3 network routes through Africa as well as to assure solutions that help businesses  transform and scale seamlessly.

He says, “Phase3 current network upgrades is an ongoing exercise and will cover security features, performance enhancements, agile update capacity, and quality delivery mechanisms for enterprise segments. Especially in the areas of productive work-from-anywhere or do-business-from-anywhere and digitized remote connectivity solutions”.

In addition to the company’s focus to increase enterprise based networks data handling capacity and their capability to access data within dissimilar sources faster vis-a-vis smarter, as today’s global clime demands.

Jegede, in his concluding statement says, “Phase3 layered digital capabilities will both enhance Phase3 network architecture and compliment legacy connectivity service experience in remote locations with significant Phase3 presence and network access points.

About Phase3 telecom

Phase3 Telecom is a leading independent fiber optic infrastructure with Points-of-Presence (POPs), colocation, and NOCs in Nigeria. Issued a National Long Distance Operator (NLDO) license in 2003 by the Nigerian Communications Commission (NCC), and with a vibrant as well as a dedicated team of experienced professionals, we are the network of choice for high-performance, data-intensive and low latency connectivity that span dedicated internet access, MPLS VPN, metro ethernet, wide area network solutions etc. We currently operate across the ECOWAS region and international markets through strategic partnerships that allow us to connect our clients across 400 cities worldwide. And ours is an extensive and secure network with end-to-end capabilities that service providers and businesses can rely on to scale, manage costs and assure efficiency. As our network continues to evolve into other layered service streams, including cloud-based and network security solutions – our invaluable clients will continue to remain the core of every investment that we make; innovation that we create; and technology that we adopt during the 4th industrial revolution to position us as the network of the future.

Continue Reading

Press Releases

Digital Therapeutics Revenue from Health Insurers to Reach $8 Billion Globally by 2026

Published

 on

Hampshire, UK – 14th March 2022: A new study from Juniper Research has found that digital therapeutics revenue from health insurers will increase to $8 billion by 2026, up from $1.1 billion in 2022; representing a growth of 610 percent over the next four years. Digital therapeutics are clinically validated software programs for the treatment of chronic medical conditions, either independently or in conjunction with other therapies.

The report found that digital therapeutics facilitate the proactive mitigation of chronic medical conditions before they require costly interventions; enabling health insurers to reduce long-term costs per patient. However, it highlighted that these savings will be limited to health insurers in developed regions, where consumer devices and digitalized health infrastructure are ubiquitous. As such, it noted that health insurers in Africa and Latin America will contribute less than 2 percent towards health insurer-led digital therapeutics revenue in 2026.

A new research, Digital Therapeutics & Wellness: Key Trends, Business Models & Market Forecasts 2022-2026, identified that insurers will also benefit from an ongoing shift among digital therapeutics vendors towards engagement- and results-based payments. It recommends that therapeutics providers looking to leverage this trend prioritize the development of performance benchmarks, as demonstrating improvement and preventing patient abandonment will become a direct monetary issue.

Machine Learning to Move into Advisory Role as Liability Issues Emerge

The report forecasts that the number of people using digital therapeutics will increase by 381% over the next four years, and recognizes that machine learning will be key to this growth by facilitating advanced data analytics, remote patient monitoring, and real-time conversational coaching. However, it cautioned that an ongoing lack of standards surrounding the use of machine learning within digital therapeutics will result in vendors limiting its role in their offerings.

Research author Adam Wears explained: “As developers and healthcare providers increasingly grapple with issues of liability and malpractice, machine learning will transition from a patient-facing role to a diagnostic tool offered through provider-facing dashboards; to be used by clinicians and specialists in a manner akin to traditional computer-aided diagnostics.”

Continue Reading

Trending